205 related articles for article (PubMed ID: 30955491)
1. An epithelial organoid model with Langerhans cells for assessing virus-host interactions.
Jackson R; Eade S; Zehbe I
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180288. PubMed ID: 30955491
[TBL] [Abstract][Full Text] [Related]
2. The rabbit papillomavirus model: a valuable tool to study viral-host interactions.
Cladel NM; Peng X; Christensen N; Hu J
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180294. PubMed ID: 30955485
[TBL] [Abstract][Full Text] [Related]
3. Modelling human papillomavirus biology in oropharyngeal keratinocytes.
Roberts S; Evans D; Mehanna H; Parish JL
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180289. PubMed ID: 30955493
[TBL] [Abstract][Full Text] [Related]
4. Evasion of host immune defenses by human papillomavirus.
Westrich JA; Warren CJ; Pyeon D
Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
[TBL] [Abstract][Full Text] [Related]
5. 3D Oral and Cervical Tissue Models for Studying Papillomavirus Host-Pathogen Interactions.
Jackson R; Maarsingh JD; Herbst-Kralovetz MM; Van Doorslaer K
Curr Protoc Microbiol; 2020 Dec; 59(1):e129. PubMed ID: 33232584
[TBL] [Abstract][Full Text] [Related]
6. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
7. [Persistent human papillomavirus infection in the etiology of cervical carcinoma: the role of immunological, genetic, viral and cellular factors].
Zivadinović R; Petrić A; Lilić G; Lilić V; Djordjević B
Srp Arh Celok Lek; 2014; 142(5-6):378-83. PubMed ID: 25033599
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human papillomaviruses with the host immune system: a well evolved relationship.
Frazer IH
Virology; 2009 Feb; 384(2):410-4. PubMed ID: 18986661
[TBL] [Abstract][Full Text] [Related]
9. Interplay between human papillomaviruses and dendritic cells.
Offringa R; de Jong A; Toes RE; van der Burg SH; Melief CJ
Curr Top Microbiol Immunol; 2003; 276():215-40. PubMed ID: 12797450
[TBL] [Abstract][Full Text] [Related]
10. Early Defensive Mechanisms against Human Papillomavirus Infection.
Moerman-Herzog A; Nakagawa M
Clin Vaccine Immunol; 2015 Aug; 22(8):850-7. PubMed ID: 26063238
[TBL] [Abstract][Full Text] [Related]
11. [Escape mechanisms to the innate immune response in HPV-associated cervical cancer].
del Toro-Arreola S; García-Chagollán M; Jave-Suárez LF
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S194-9. PubMed ID: 26462516
[TBL] [Abstract][Full Text] [Related]
12. HPV modulation of host immune responses.
Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
[TBL] [Abstract][Full Text] [Related]
13. Host responses to infection with human papillomavirus.
Stanley MA; Sterling JC
Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.
Da Silva DM; Movius CA; Raff AB; Brand HE; Skeate JG; Wong MK; Kast WM
Virology; 2014 Mar; 452-453():279-86. PubMed ID: 24606705
[TBL] [Abstract][Full Text] [Related]
15. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.
Amador-Molina A; Hernández-Valencia JF; Lamoyi E; Contreras-Paredes A; Lizano M
Viruses; 2013 Oct; 5(11):2624-42. PubMed ID: 24169630
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
17. APOBEC-mediated genomic alterations link immunity and viral infection during human papillomavirus-driven cervical carcinogenesis.
Chen L; Qiu X; Zhang N; Wang Y; Wang M; Li D; Wang L; Du Y
Biosci Trends; 2017 Sep; 11(4):383-388. PubMed ID: 28717061
[TBL] [Abstract][Full Text] [Related]
18. Vaccines and immunization against human papillomavirus.
Christensen ND; Budgeon LR
Curr Probl Dermatol; 2014; 45():252-64. PubMed ID: 24643192
[TBL] [Abstract][Full Text] [Related]
19. Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections.
Leong CM; Doorbar J; Nindl I; Yoon HS; Hibma MH
J Invest Dermatol; 2010 Feb; 130(2):472-80. PubMed ID: 19759549
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion mechanisms of human papillomavirus: An update.
Steinbach A; Riemer AB
Int J Cancer; 2018 Jan; 142(2):224-229. PubMed ID: 28865151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
